BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine
<i>Background:</i> Intra-vesical instillation of <i>Bacille Calmette−Guérin</i> (BCG), an attenuated strain of <i>Mycobacterium bovis</i>, is an effective therapy for high-grade non-muscle invasive bladder cancer (NMIBC), which provokes a local...
Main Authors: | Omodele Ashiru, Gloria Esteso, Eva M. García‐Cuesta, Eva Castellano, Celia Samba, Eva Escudero-López, Sheila López‐Cobo, Mario Álvarez-Maestro, Ana Linares, Mei M. Ho, Asier Leibar, Luis Martínez‐Piñeiro, Mar Valés‐Gómez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/7/940 |
Similar Items
-
Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC
by: Roberto Martínez, et al.
Published: (2019-08-01) -
Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes
by: Eva M. García-Cuesta, et al.
Published: (2017-04-01) -
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy
by: Cyrill A. Rentsch, et al.
Published: (2020-01-01) -
Natural Killer Anti-Tumor Activity Can Be Achieved by In Vitro Incubation With Heat-Killed BCG
by: Gloria Esteso, et al.
Published: (2021-02-01) -
Microevolution of BCG substrains
by: Katarzyna Krysztopa‑Grzybowska, et al.
Published: (2016-12-01)